ArticleRadiation oncology (London, England)2022

Predicting 2-year survival in stage I-III non-small cell lung cancer: the development and validation of a scoring system from an Australian cohort.

Natalie Si-Yi Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.